X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (484) 484
Publication (64) 64
Book Chapter (7) 7
Patent (4) 4
Book / eBook (1) 1
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (245) 245
heart failure (220) 220
index medicus (215) 215
cardiac & cardiovascular systems (189) 189
male (173) 173
female (154) 154
heart failure - drug therapy (131) 131
aged (118) 118
middle aged (115) 115
mortality (114) 114
acute disease (93) 93
cardiovascular (83) 83
heart failure - physiopathology (82) 82
treatment outcome (82) 82
acute heart failure (71) 71
heart failure - mortality (62) 62
prognosis (62) 62
cardiac patients (59) 59
hospitalization (57) 57
double-blind method (55) 55
outcomes (51) 51
clinical trials (50) 50
drug therapy (45) 45
abridged index medicus (44) 44
article (41) 41
association (38) 38
heart (38) 38
heart failure - therapy (38) 38
risk factors (38) 38
heart failure - diagnosis (36) 36
aged, 80 and over (35) 35
analysis (35) 35
cardiology (35) 35
care and treatment (35) 35
heart failure - blood (35) 35
heart failure - complications (34) 34
animals (33) 33
dose-response relationship, drug (33) 33
rolofylline (33) 33
internal medicine (29) 29
patients (29) 29
survival (29) 29
biomarkers (27) 27
risk (27) 27
trial (27) 27
medical colleges (26) 26
research (26) 26
time factors (26) 26
double-blind (25) 25
biomarkers - blood (24) 24
cardiology and cardiovascular medicine (24) 24
health aspects (24) 24
randomized controlled trials as topic (24) 24
adult (23) 23
antagonist (23) 23
heart attacks (23) 23
myocardial-infarction (23) 23
proportional hazards models (23) 23
serelaxin (23) 23
diuretics (22) 22
medicine & public health (22) 22
stroke (22) 22
dysfunction (21) 21
dyspnea (21) 21
follow-up studies (21) 21
medical research (21) 21
multivariate analysis (21) 21
task-force (21) 21
disease (20) 20
umcg approved (20) 20
heart failure - epidemiology (19) 19
infusions, intravenous (19) 19
relaxin - therapeutic use (19) 19
renal-function (19) 19
stroke volume (19) 19
survival rate - trends (19) 19
clinical-trials (18) 18
disease progression (18) 18
hemodynamics (18) 18
medicine, experimental (18) 18
patient outcomes (18) 18
peripheral vascular disease (18) 18
therapy (18) 18
vasodilator agents - therapeutic use (18) 18
xanthines - therapeutic use (18) 18
cardiovascular disease (17) 17
preserved ejection fraction (17) 17
aspirin (16) 16
blood pressure (16) 16
diagnosis (16) 16
diuretics - therapeutic use (16) 16
hospitalization - statistics & numerical data (16) 16
prospective studies (16) 16
relaxin - administration & dosage (16) 16
risk assessment (16) 16
chronic disease (15) 15
clinical trials as topic (15) 15
heart diseases (15) 15
management (15) 15
medicine, general & internal (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Heart Journal, ISSN 0195-668X, 2017, Volume 38, Issue 5, pp. 317 - 325
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2019, Volume 381, Issue 8, pp. 716 - 726
In a randomized trial, 6545 patients with acute heart failure were assigned to either serelaxin or placebo in addition to standard care. There were no... 
Heart failure | Usage | Cardiovascular diseases | Drug therapy | Relaxin | Patient outcomes | Adaptations | Intravenous administration | Kidneys | Peptides | Mortality | Body weight | Committees | Patients | Pregnancy | Radiography | Design | Renal insufficiency | Dyspnea | Motivation | Renal failure | Death | Blood pressure | Respiration | Heart diseases
Journal Article
LANCET, ISSN 0140-6736, 08/2011, Volume 378, Issue 9792, pp. 713 - 721
Understanding of contemporary pharmacological therapy for chronic heart failure continues to evolve. In this Review, we discuss how findings from clinical... 
VENTRICULAR EJECTION FRACTION | CONVERTING ENZYME-INHIBITOR | VASOPRESSIN ANTAGONIST | MEDICINE, GENERAL & INTERNAL | ANGIOTENSIN-RECEPTOR BLOCKER | OMECAMTIV MECARBIL | CARDIAC MYOSIN ACTIVATOR | DOUBLE-BLIND | EXERCISE CAPACITY | SYSTOLIC FUNCTION | RANDOMIZED TRIAL | Heart failure | Clinical trials | Heart attacks | Drug therapy | Mortality
Journal Article
The Lancet, ISSN 0140-6736, 2013, Volume 381, Issue 9880, pp. 1813 - 1814
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 20, pp. 1859 - 1869
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2015, Volume 66, Issue 1, p. 99
  The authors provide very interesting data from their own laboratory on the possible role of serelaxin in modulating cardiac fibrosis, myocyte hypertrophy,... 
Heart failure | Clinical outcomes
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2015, Volume 66, Issue 1, p. 99
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2015, Volume 66, Issue 1, p. 99
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 08/2015, Volume 17, Issue 8, pp. 750 - 752
Journal Article
JACC: Heart Failure, ISSN 2213-1779, 07/2018, Volume 6, Issue 7, pp. 561 - 563
Journal Article
Circulation, ISSN 0009-7322, 2015, Volume 131, Issue 1, pp. 54 - 61
Journal Article